Woburn, Massachusetts Clinical Trials

A listing of Woburn, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 80 clinical trials
Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer

This is a first in human study to assess the safety, tolerability, PK, PD and preliminary efficacy of CC-94676 in men with progressive metastatic castration-resistant prostate cancer.

gonadotropin releasing hormone
androgen suppression
androgens
orchiectomy
cancer
Dana Farber Cancer Institute
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

Metro Boston Clinical Partners- Site Number : 8400008
 (9.4 away) Contact site
  • 0 views
  • 29 Nov, 2025
  • +30 other locations
Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC

The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood. This research study involves the following investigational drugs: Ipatasertib Atezolizumab

anticoagulants
cancer
g-csf
sentinel lymph node biopsy
adjuvant
Dana-Farber Cancer Institute
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Cisplatin+Pembrolizumab+RT in Vulvar Cancer

This research is being done to see how well the combination of a standard of care drug, investigational drug, and radiation therapy work against unresectable vulvar squamous cell carcinoma. This research study involves the following: Cisplatin (standard of care drug) Pembrolizumab (investigational drug) Radiation Therapy (standard of care intervention)

anticoagulants
pembrolizumab
cisplatin
cancer
total bilirubin
Massachusetts General Hospital Cancer Center
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Preoperative Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD

Prior studies have shown that left ventricular assist device (LVAD) implantation commonly results in right ventricular failure (RVF). Right ventricular dysfunction and failure after LVAD implantation is known to increase morbidity and mortality and contribute to longer post-implant hospital length of stay. Since RVF is difficult to predict and can …

ventricular dysfunction
right ventricular failure
Massachusetts General Hospital
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

This clinical trial is studying two immunotherapy drugs (nivolumab and ipilimumab) given together as a possible treatment for INI1-negative tumors.

cancer treatment
growth factor
monoclonal protein
epithelioid sarcoma
cancer
Dana-Farber Cancer Institute
 (9.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women

The postpartum period is a critical time for both maternal and child health, and more than half of all maternal deaths occur postpartum, from one day to one year after birth. This poor outcome is linked to the racial and ethnic disparities that disproportionately effects low income and black women. …

HealthCore
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Genome Environment Microbiome and Metabolome in Autism Study

GEMMA is a multicenter longitudinal observational study that follows children who are genetically at-risk of developing autism for their first three years of life, seeking to identify potential biomarkers predictive of autism development in the blood, stool, urine and saliva. The biomarkers identified in this project will contribute to a …

autism
Massachusetts General Hospital for Children
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

imiglucerase
deficiency
eliglustat
gaucher disease
Investigational Site Number 840062
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840062
 (9.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +135 other locations